01 May 2004
The Australian experience in organ donation--2003.
Timothy MathewAnn Transplant 2004; 9(1): 28-30 :: ID: 142797
Abstract
The Australian performance in deceased donor organ donation continues tolanguish near the bottom of the International ladder. This is despite a national expenditure on health10% more than the average OECD country (dollars per capita) and the presence of active transplantationprograms (heart, kidney, liver, lung and pancreas) with excellent success rates. The deceased donor ratehas fallen from 14 donors pmp in 1989 to 9 at the present time and appears to be still falling. Livingdonors now outnumber deceased donors as a source of kidney transplants. Causes of the low deceased donorrate appear to include variable management of severe brain injury, shortage of ICU beds, lack of ICUpriority to potential donors when beds are restricted, and a low family consent rate (50%) despite 83%of the public being willing to donate. Programs aimed at addressing these issues are planned and includeadditional funding for beds, improved identification of donors and a standard pathway for managing severebrain injury.
Keywords: Tissue Donors - statistics & numerical data
In Press
Case report
Tongue Carcinoma in Immunosuppressed Patients After Liver and Kidney Transplantation: A Case SeriesAnn Transplant In Press; DOI: 10.12659/AOT.951715
Original article
Prevalence and Risk Factors of Hepatic Steatosis in Kidney Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.952251
Original article
The Anatomical Landscape of Living Donor Livers: A 101-Case Retrospective Single-Center Study in Indonesia ...Ann Transplant In Press; DOI: 10.12659/AOT.952031
Original article
Decreased Ventilation Duration and ICU Stay Associated With Early Percutaneous Dilatational Tracheostomy Af...Ann Transplant In Press; DOI: 10.12659/AOT.953143
Most Viewed Current Articles
24 Aug 2021 : Review article 20,545
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 16,641
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
05 Apr 2022 : Original article 15,898
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 15,796
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988






